Dr. Mewawalla speaks to oncologists, care teams, and patient communities about how to choose, sequence, and safely deliver CAR T-cell therapy and bispecific antibodies, including beyond major academic centers.
Presenting the most important practice-changing advances in multiple myeloma. "What makes these meetings valuable is not just discussing new developments, it is examining how we translate that evidence into better treatment selection, thoughtful sequencing, and meaningful outcomes for our patients."
Invited lectures, panels, and plenaries across national and international myeloma and cellular therapy meetings.















Community & academic oncologists · advanced-practice providers & nursing · tumor boards & grand rounds · patient & caregiver groups · industry medical/scientific meetings.
Plenary & lectures · CME lectures · panel moderation & participation · case-based workshops · fireside chats · virtual webinars & podcasts.
High-resolution headshots · slide previews · learning objectives · disclosure statement · ready-to-use biographies.
Print-ready headshots and ready-to-use biographies for programs and introductions.